170.35
price up icon2.77%   4.59
after-market After Hours: 171.35 1.00 +0.59%
loading
Natera Inc stock is traded at $170.35, with a volume of 1.06M. It is up +2.77% in the last 24 hours and up +2.28% over the past month. Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$165.76
Open:
$170.33
24h Volume:
1.06M
Relative Volume:
0.89
Market Cap:
$20.92B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-96.79
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
-3.54%
1M Performance:
+2.28%
6M Performance:
+51.21%
1Y Performance:
+179.77%
1-Day Range:
Value
$167.37
$173.87
1-Week Range:
Value
$163.42
$183.00
52-Week Range:
Value
$59.80
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Name
Natera Inc
Name
Phone
650-249-9090
Name
Address
13011 MCCALLEN PASS, AUSTIN, CA
Name
Employee
3,293
Name
Twitter
@nateragenetics
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
NTRA's Discussions on Twitter

Compare NTRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
NTRA
Natera Inc
170.35 20.92B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
551.47 210.94B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
237.97 171.88B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
142.23 40.62B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
196.10 35.59B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
422.92 34.63B 3.84B 866.24M 792.60M 10.37

Natera Inc Stock (NTRA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-03-24 Resumed Jefferies Buy
Apr-08-24 Resumed Craig Hallum Buy
Feb-20-24 Downgrade Raymond James Strong Buy → Outperform
Dec-29-23 Reiterated BTIG Research Buy
Dec-14-23 Initiated Guggenheim Buy
Dec-13-23 Initiated Wolfe Research Outperform
Nov-13-23 Upgrade Raymond James Outperform → Strong Buy
Sep-28-23 Initiated Bernstein Mkt Perform
Jul-05-23 Resumed JP Morgan Overweight
May-05-23 Initiated UBS Buy
Jan-18-23 Upgrade Raymond James Mkt Perform → Outperform
Aug-25-22 Initiated Credit Suisse Outperform
Apr-25-22 Initiated Stephens Overweight
Mar-08-22 Initiated Goldman Buy
Jan-06-22 Resumed Piper Sandler Overweight
Oct-15-21 Resumed Cowen Outperform
Jun-15-21 Initiated Raymond James Mkt Perform
May-25-21 Initiated Wells Fargo Overweight
Jan-28-21 Initiated Truist Buy
Oct-08-20 Initiated BTIG Research Buy
Sep-28-20 Initiated Morgan Stanley Overweight
Sep-17-20 Initiated SVB Leerink Outperform
Jun-10-20 Resumed Piper Sandler Overweight
May-07-20 Upgrade JP Morgan Neutral → Overweight
Oct-05-18 Initiated JP Morgan Neutral
Jul-05-18 Reiterated Piper Jaffray Overweight
Aug-07-17 Reiterated Morgan Stanley Overweight
Nov-10-16 Reiterated The Benchmark Company Buy
May-23-16 Reiterated The Benchmark Company Buy
May-11-16 Reiterated The Benchmark Company Buy
Apr-19-16 Initiated The Benchmark Company Buy
Sep-28-15 Upgrade Wedbush Neutral → Outperform
Aug-14-15 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-04-15 Initiated Robert W. Baird Outperform
Jul-27-15 Initiated Morgan Stanley Equal-Weight
Jul-27-15 Initiated Piper Jaffray Overweight
Jul-27-15 Initiated Wedbush Neutral
View All

Natera Inc Stock (NTRA) Latest News

pulisher
09:27 AM

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection - BioSpace

09:27 AM
pulisher
07:00 AM

Natera Unveils Revolutionary Cancer Detection Tech with 92% Early-Stage Accuracy - StockTitan

07:00 AM
pulisher
Jan 14, 2025

Sheena Jonathan Natera Stock Sale Highlights Insider Confidence Amid Legal and Financial Milestones - HPBL

Jan 14, 2025
pulisher
Jan 14, 2025

Natera (NASDAQ:NTRA) Reaches New 12-Month HighTime to Buy? - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Natera (NASDAQ:NTRA) Shares Gap Up Following Analyst Upgrade - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Natera guides Q4 and FY revenue above consensus - MSN

Jan 13, 2025
pulisher
Jan 13, 2025

Why Natera Stocks Are Gaining Attention - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Non-Invasive Prenatal Testing Market Top Companies Study - openPR

Jan 13, 2025
pulisher
Jan 12, 2025

Natera Shatters Growth Records: Q4 Revenue Surges 52% to $472M, Oncology Tests Jump 55% - StockTitan

Jan 12, 2025
pulisher
Jan 12, 2025

Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024 - Business Wire

Jan 12, 2025
pulisher
Jan 12, 2025

Insider Sell Alert: Daniel Rabinowitz Sells 6,223 Shares of Nate - GuruFocus.com

Jan 12, 2025
pulisher
Jan 12, 2025

Harbor Capital Advisors Inc. Trims Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Jan 12, 2025
pulisher
Jan 11, 2025

Natera's chief legal officer sells $1.09 million in stock - Investing.com India

Jan 11, 2025
pulisher
Jan 10, 2025

Natera’s chief legal officer sells $1.09 million in stock By Investing.com - Investing.com Nigeria

Jan 10, 2025
pulisher
Jan 10, 2025

The Analyst Verdict: Natera In The Eyes Of 14 Experts - Benzinga

Jan 10, 2025
pulisher
Jan 10, 2025

Sanford C. Bernstein Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings - The Motley Fool

Jan 09, 2025
pulisher
Jan 09, 2025

Natera, Inc. (NASDAQ:NTRA) Shares Sold by First Hawaiian Bank - MarketBeat

Jan 09, 2025
pulisher
Jan 08, 2025

Natera Stock Soars to All-Time High of $175.68 By Investing.com - Investing.com Nigeria

Jan 08, 2025
pulisher
Jan 08, 2025

Natera (NASDAQ:NTRA) Reaches New 1-Year HighShould You Buy? - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Natera Stock Soars to All-Time High of $175.68 - Investing.com India

Jan 08, 2025
pulisher
Jan 07, 2025

Ravgen wins $57M in patent infringement suit against Natera - LabPulse

Jan 07, 2025
pulisher
Jan 07, 2025

Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 07, 2025
pulisher
Jan 06, 2025

3,984 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Silverleafe Capital Partners LLC - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Natera Fails to Expand $96 Million Patent Win Over CareDx (1) - Bloomberg Law

Jan 06, 2025
pulisher
Jan 06, 2025

(NTRA) Technical Data - Stock Traders Daily

Jan 06, 2025
pulisher
Jan 05, 2025

Everence Capital Management Inc. Acquires Shares of 3,620 Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Jan 05, 2025
pulisher
Jan 05, 2025

Everence Capital Management Inc. Makes New $573,000 Investment in Natera, Inc. (NASDAQ:NTRA) - Defense World

Jan 05, 2025
pulisher
Jan 03, 2025

Natera co-founder Sheena Jonathan sells $909k in stock By Investing.com - Investing.com Nigeria

Jan 03, 2025
pulisher
Jan 03, 2025

Natera co-founder Sheena Jonathan sells $909k in stock - Investing.com

Jan 03, 2025
pulisher
Jan 03, 2025

Natera Loses New Trial Bid After Winning $96M Patent Verdict - Law360

Jan 03, 2025
pulisher
Jan 03, 2025

Undercovered Dozen: Natera, Lloyds Banking Group, Eaton, Primoris Services + - Seeking Alpha

Jan 03, 2025
pulisher
Jan 03, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - MarketBeat

Jan 03, 2025
pulisher
Jan 01, 2025

Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years - Yahoo Finance

Jan 01, 2025
pulisher
Dec 31, 2024

Natera: Poised For A Great Future But I'd Wait For A Pullback (NASDAQ:NTRA) - Seeking Alpha

Dec 31, 2024
pulisher
Dec 30, 2024

Invitae Fights Natera's Bid to Amplify $19 Million Patent Win - Bloomberg Law

Dec 30, 2024
pulisher
Dec 30, 2024

Is Natera (NASDAQ:NTRA) Weighed On By Its Debt Load? - Simply Wall St

Dec 30, 2024
pulisher
Dec 29, 2024

Analysts Set Natera, Inc. (NASDAQ:NTRA) Price Target at $152.67 - MarketBeat

Dec 29, 2024
pulisher
Dec 27, 2024

Natera president Solomon Moshkevich sells $387,511 in stock By Investing.com - Investing.com Nigeria

Dec 27, 2024
pulisher
Dec 26, 2024

Natera, Inc. (NASDAQ:NTRA) Insider John Fesko Sells 669 Shares - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Natera’s president sells $106,773 in company stock By Investing.com - Investing.com Nigeria

Dec 26, 2024
pulisher
Dec 26, 2024

Natera's president sells $106,773 in company stock By Investing.com - Investing.com South Africa

Dec 26, 2024
pulisher
Dec 26, 2024

Natera's president sells $106,773 in company stock - Investing.com India

Dec 26, 2024
pulisher
Dec 26, 2024

Natera president Solomon Moshkevich sells $387,511 in stock - Investing.com

Dec 26, 2024
pulisher
Dec 26, 2024

(NTRA) Proactive Strategies - Stock Traders Daily

Dec 26, 2024
pulisher
Dec 23, 2024

Tidal Investments LLC Trims Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Dec 23, 2024
pulisher
Dec 23, 2024

Sanctuary Advisors LLC Has $950,000 Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Dec 23, 2024
pulisher
Dec 21, 2024

Principal Financial Group Inc. Purchases 28,751 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Dec 21, 2024
pulisher
Dec 20, 2024

Natera co-founder Sheena Jonathan sells $953,337 in stock - Investing.com India

Dec 20, 2024
pulisher
Dec 20, 2024

Natera co-founder Sheena Jonathan sells $953,337 in stock By Investing.com - Investing.com UK

Dec 20, 2024

Natera Inc Stock (NTRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$136.19
price down icon 0.21%
diagnostics_research LH
$237.30
price up icon 1.19%
diagnostics_research WAT
$397.70
price down icon 1.79%
diagnostics_research MTD
$1,279.73
price up icon 0.66%
$422.92
price up icon 1.02%
Cap:     |  Volume (24h):